Drug Discovery Technology Alert. Advances in Locked Nucleic Acid-Based Technology Platforms for Drug Discovery and Development; Managing Parkinson’s Disease through Endogenous Neurotransmitter Serotonin Receptor Agonists
This issue profiles advances in locked nucleic acid-based technology platforms for drug discovery and development, managing parkinson’s disease through endogenous neurotransmitter serotonin receptor agonists, low-dose mobilized bone marrow for diabetes therapy.
Click headings to expand and collapse
Published: 11 May 2012
Tools
Features of this research
Help Desk
For more information and general enquiries, contact Frost & Sullivan near you.
Select a location near you..